guiding you onto the right path

Latest Jobs

Purpose: Acting as the key interface with clients over projects, manages the timely delivery of project outputs in line with client expectations. Dev...
Purpose: Manages the delivery of client project(s), ensuring delivery of the project in line with client objectives and expectations as well as proje...

HEOR Analyst

Overview of the role

Analyst is the normal entry level for those who have just completed a Masters degree in Health Economics or (less frequently) a similar Masters course. Analysts have an important role within the HEOR practice and are expected to develop their skills and knowledge by taking on a wide range of tasks whilst maximising opportunities to learn from colleagues. All Analysts have a mentor at Senior Consultant level or above, who is responsible for supporting their professional development and ensuring that they receive the expected range of experience and formal training. Analysts also have the opportunity to contribute to business development, mainly by drafting proposals in response to RFPs.

 

REQUIRED KNOWLEDGE

A good knowledge of HEOR methods and approaches and a understanding of the health care sector and the pharmaceutical market, gained through study and (ideally) internships or previous healthcare experience.

RESPONSIBILITIES

General

  • Carry out work relating to the HEOR business areas (health economic modelling, HTA submissions, value communication, market access strategy and outcomes research) to a high standard which meets or exceeds client expectations.
  • Work with supervision independently and/or as part of a project team on defined tasks.
  • Produce draft reports relating to ad-hoc HEOR projects if required.

 

Business development / internal initiatives

  • Produce partial initial drafts of proposals based on client RFPs and supporting information.
  • Participate in internal initiatives eg internal disseminations and make oral presentations to colleagues if required, supported by more senior colleagues.

 

Project management / Client liaison

  • Assist on specific project or client management tasks under the supervision of a more senior colleague
  • Attend client and other external meetings in the home base country and elsewhere in Europe and the US, accompanied by a more senior colleague
  • Make oral presentations of own research / analysis to clients

 

 

Product-specific

Health economic modelling

  • Produce draft analysis plans for simple health economic models and provide input to their further development.
  • Input to the development of complex health economic models.
  • Review literature to source the required inputs (costs and clinical) to health economics models and analyses. Input this data to models if necessary.
  • Produce support materials for completed economic models, e.g. reports and training programmes.

 

HTA submissions

  • Write chapters of submission documents for national and international HTA, market access and reimbursement organisations (NICE, SMC, PBAC etc).

 

Literature and data review

  • With support, develop search strategies for structured and systematic literature reviews.
  • Carry out abstract review, paper selection and data extraction.
  • Write literature review reports.
  • Carry out grey literature reviews
  • Assist specialists within the HEOR team in conducting meta analyses and indirect comparisons.

 

Medical writing for value communication

  • Write clinical and economic chapters for product value dossiers and value communications support material for clients, including the development of value messages.
  • Draft abstracts, posters and manuscripts for publication based on economic models, literature reviews, meta-analyses and other HEOR work. Assist in the submission process.

 

Retrospective data analysis

  • Extract data from databases for outcomes research projects and support materials e.g. protocols.
  • Draft sections of reports for clients, eg methodology.

 

Market access strategy

  • Carry out research and draft reports for projects delivering strategic advice to clients on pricing, reimbursement and market access.

 

 

QUALIFICATIONS, EXPERIENCE, TECHNICAL AND PERSONAL SKILLLS

 

Essential qualifications

  • MSc in science, economics or a related discipline
  • Postgraduate qualification in health economics, health services research or a relevant related area.

 

Essential personal skills and behaviours

  • Fluency in English (spoken and written); strong business/scientific written English
  • Strong written and verbal communication skills
  • A commitment to working collaboratively and effectively with others in and across the team to accomplish goals
  • A commitment to timely internal and client communication; with clients, project managers and team members,  colleagues and others
  • Good team-based interpersonal skills but also an ability to work independently
  • A pragmatic and logical problem solving approach to projects
  • Strong attention to detail on all project deliverables even under time pressure.
  • Good time management and personal organisational skills
  • An enthusiastic and flexible approach to work within the HEOR business area and willingness to contribute to all types of project undertaken by the team.

 

Essential general technical skills and knowledge

  • Numerate and good quantitative skills - able to work in Excel to at least Intermediate level and able to provide evidence of this applied in A work or academic setting
  • Competency in using Word and PowerPoint and an interest in learning relevant decision-support and statistical packages
  • High level of literacy – able to appraise evidence critically and write reports and manuscripts in clear, concise language as required by the type of work.
  • Ability to quality check own work so that drafts are delivered with only minimal minor typographical errors
  • Good understanding of outcomes research and/or economic theory and the ability to apply this in practice

 

 

Desirable general technical skills and knowledge

  • Good understanding of and interest in the international health care environment
  • Commercial awareness and good understanding of the health technology and pharmaceutical industry

 

Desirable experience

  • Post graduate work experience in a related area such as economics, health economics, statistics, psychology or science

 

  • Experience of working in health economics/outcomes research/health services research.

 

  • Experience in undertaking economic analysis in one of the following environments:
  • Pharmaceutical or other Healthcare Industry
  • Academic Organisation   
  • Health Technology Assessment Group
  • Health Services Research
Job Type:
Permanent
Experience:
Bachelors Degree
Location:
London
Sector:
Health Economics & Outcomes Research
Salary:
£Negotiable
Ref:
103

How to apply

Apply Now

Latest News

Fri, 25 Apr 2025 10:00:00 +0200
Chemists have confirmed a 67-year-old theory about vitamin B1 by stabilizing a reactive molecule in water - a feat long thought impossible. The discovery not only solves a biochemical mystery, but also opens the door to greener, more efficient ways of making pharmaceuticals.

The molecule in question is a carbene, a type of carbon atom with only six valence electrons. Generally, carbon is stable with eight electrons around it. With only six electrons, it is chemically unstable and highly reactive.

Thu, 24 Apr 2025 10:00:00 +0200
Antibodies are best known for their ability to latch onto and neutralize bacteria, viruses and other pathogens. But these immune proteins can do more than that: They also activate other components of the immune system, which then go to work to clear an infection. A new study from Scripps Research explores the factors that influence how effectively antibodies engage specific immune cells.

Their results, described April 22, 2025 in Cell Reports, indicate that a higher ratio of antibodies to viral protein - in this case, a part of HIV - better engages two specific types of immune cells.

Wed, 23 Apr 2025 10:00:00 +0200
BayerBlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, announced the publication of the 18-month data from its Phase 1 exPDite clinical trial for bemdaneprocel in the journal Nature.

"The concept of "rebuilding" brain networks that have been lost to disease is compelling," said Claire Henchcliffe, MD, chair of the UC Irvine School of Medicine's Department of Neurology at the University of California, Irvine and one of the study's Principal Investigators,

Tue, 22 Apr 2025 10:00:00 +0200
When the immune system does not function properly, individuals become more susceptible to infections caused by viruses, bacteria, or fungi. Researchers from Radboud university medical center have demonstrated that an existing drug can revive immune cells that are not functioning correctly. These findings provide leads for further research in patients admitted to the intensive care unit (ICU) with sepsis.
Mon, 21 Apr 2025 10:00:00 +0200
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led by University of Arizona Cancer Center researchers and published in the Journal of Clinical Investigation.

Merkel cell carcinoma is a rare but fast-growing neuroendocrine cancer that is three to five times more likely than melanoma to be deadly.

Fri, 18 Apr 2025 10:00:00 +0200
While organoids aim to mimic human organs, the liver's repertoire of complex functions - and thus the energy it needs to operate - have made it challenging for researchers to grow organoids that proliferate and fully function, says Sato. When prioritizing growth and survival in laboratory settings, hepatocytes, the liver's main cells, eventually transformed into cells resembling cholangiocytes, which line the bile duct. Hepatocyte functions only lasted 1-2 weeks at most.
Thu, 17 Apr 2025 10:00:00 +0200
A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.

In research published in JAMA Neurology on April 7, UF researchers studied Medicare claims data of older adults with Type 2 diabetes to assess the association among glucagon-like peptide-1 receptor agonists, or GLP-1RAs, sodium-glucose cotransporter-2 inhibitors, or SGLT2is, and the risk of Alzheimer's disease and related dementias.

Wed, 16 Apr 2025 10:00:00 +0200
A stem cell-based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 clinical trial reported in Nature.

The treatment involved creating nerve cells (neurons) derived from embryonic stem cells and transplanting them into the brains of 12 Parkinson's patients.

Tue, 15 Apr 2025 10:00:00 +0200
University of California, Davis researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.

The research, published in Proceedings of the National Academy of Sciences, highlights the new drug's potential as a treatment option for conditions like schizophrenia, where psychedelics are not prescribed for safety reasons.

Mon, 14 Apr 2025 10:00:00 +0200
Is sauerkraut more than just a tangy topping? A new University of California, Davis, study published in Applied and Environmental Microbiology suggests that the fermented cabbage could help protect your gut, which is an essential part of overall health, supporting digestion and protecting against illness.

Authors Maria Marco, professor with the Department of Food Science and Technology, and Lei Wei, a postdoctoral researcher in Marco's lab, looked at what happens during fermentation - specifically, how the metabolites in sauerkraut compared to those in raw cabbage.

Fri, 11 Apr 2025 10:00:00 +0200
Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. In a paper published in Nature, researchers from Mass General Brigham used preclinical models to uncover Tim-3's role in microglia, the brain's resident immune cells, and have identified it as a promising therapeutic target for Alzheimer's disease.
Thu, 10 Apr 2025 10:00:00 +0200
Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior and resistance to immunotherapies. The study sheds light on how tumor cells exploit the amino acid arginine to both fuel their growth and evade the immune system.

The research was led by Prof. HU Hai, who holds dual appointments as professor at the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences (CAS), and Chief Physician at Zhejiang Cancer Hospital, in collaboration with Prof. LUO Manli from Sun Yat-Sen University and Prof. LI Hongde from HIM.

Wed, 09 Apr 2025 10:00:00 +0200
Meeting the unmet need for a vaccine is the top priority for researchers studying Lyme disease, which infects about 476,000 people in the U.S. each year and can come with severe complications such as ongoing fatigue and joint issues. Vaccine developers have come close to success, but no human vaccine has yet been commercially viable.

After decades of trial and error, a promising new target is emerging - the Lyme bacterial protein CspZ, which the bacteria use to evade detection from the body's immune system.

Tue, 08 Apr 2025 10:00:00 +0200
A significant discovery has identified a missing "gatekeeper" protein as the root cause of dry mouth in Sjögren's syndrome - a finding that could change the way the disease is treated. Researchers pinpointed tricellulin, a protein that helps seal the junctions between saliva gland cells, as the key factor. When inflammation damages tricellulin, saliva production stops and harmful substances leak through.
Mon, 07 Apr 2025 10:00:00 +0200
Every year, millions of people around the world suffer ischemic strokes that block blood flow to a region of the brain.

Restoring blood flow rapidly is decisive and can save lives. But paradoxically, it can also lead to further damage to the blood vessels in the brain.

Fri, 04 Apr 2025 10:00:00 +0200
Gene therapy, a technique that is revolutionizing the treatment of multiple genetic conditions, including eye and muscle diseases and blood disorders, requires efficient and specific delivery of the genetic material to the tissue and cell type of interest. To help improve gene therapy, a multidisciplinary team led by researchers at Baylor College of Medicine, the Jackson Laboratory and the University of Massachusetts Medical School has generated a comprehensive atlas that researchers can use to select the most effective viral vehicle for their target organ.
Thu, 03 Apr 2025 10:00:00 +0200
PfizerPfizer Inc. (NYSE: PFE) announced that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO®, the company's bivalent respiratory syncytial virus (RSV) prefusion F (RSVpreF) vaccine, to extend the indication to include prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals 18 through 59 years of age. This expands the previous authorization for individuals aged 60 and older, and ABRYSVO now offers in the EU the broadest RSV vaccine indication, which includes:
Wed, 02 Apr 2025 10:00:00 +0200
A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified a promising new drug target for acute myeloid leukemia (AML), a deadly blood cancer with a five-year survival rate of just 30%, according to the National Cancer Institute. Their study, published in Cell Stem Cell in February, highlights the crucial role of a protein called paraspeckle component 1 (PSPC1) in the progression of AML.
Tue, 01 Apr 2025 10:00:00 +0200
People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, including lower risk of Alzheimer's disease related dementia, shows a study published online today in the Journal of Neurology Neurosurgery & Psychiatry.

Use of statins conveyed an additional protective effect for people with low LDL-C, specifically those with blood levels less than 1.8 mmol/L (<70 mg/dL), reducing their risk of dementia even further.

Mon, 31 Mar 2025 10:00:00 +0200
Researchers develop innovative phospholipids that improve the functional delivery of mRNA via lipid nanoparticles, paving the way for advanced therapeutic applications.

A groundbreaking study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable of significantly enhancing the functional delivery of mRNA. The study was published in the Advanced Science.

Upload Your CV

Need help finding that new job? Leave your details with us and request a call back from one of our consultants.

Submit A Vacancy

Looking to expand? Or a vacancy has become available in your business then let us know and we can find the right person for you